History
Company
History
2021
Signed a co-development agreement of Novel anticancer drug discovery with KYNOGEN (2021.1.22.)
2020
Signed a M.O.U with University of Groningen (2020.1.3)
Exhibited “Pharmulator Ver. 1.0” at CES2020 (2020.1.7)
"Pharmulator" Domestic Showcase at COEX (2020. 2.4.)
Licensing of Novel Oral Anti-Coagulant compound targeting Factor IX to Leto Science (2020. 3.11.)
Co-development and licensing Agreement with Genesen Co., on developing Multiple Sclerosis targeting S1PR5 (2020.3.23.)
Joint Development Consortium on developing COVID19 vaccine (2020.3.31.)
CEO gave a special lecture in the national pharma-bio forum (2020.4.23.)
Signed MOU with Pusan National Univ. for AI-based novel drug development (2020.5.6.)
Joined COVID19 Vaccine development consortium (2020.5.29.)
Participated in BIO USA 2020 (2020.6.9.)
Signed MOU with Korea Institute of Radiological Medical Sciences (KIRAM) (2020.8.31.)
Signed a co-development agreement of COVID19 Vaccine with Eyegene (2020.9.9.)
Signed a co-development agreement of Alzheimer’s disease novel drug with ADEL (2020.9.28.)
Designated as a special military service company (2020.10.15.)
Signed co-development agreement of drug candidate optimization with Huons (2020.12.16.)
2019
Founded : 2019.3.5. (Headquarters : in Busan)
Pharmulator System Development
Seoul Branch (2019.3.20.)
Venture Business Certification (2019.8.21.)
Kosin Gospel University Hospital MOU (2019.10.21.)
2008~2018
Dr.Wu’s Research
Enhanced Sampling(2008)
Protein-protein interactions (Docking & MD)(2009)
Protein-Quantum Computation(2012)
Blood coagulation proteins
Protein networking theory
Warfarin & Vitamin K epoxide reductase
